The relationship between coronary artery disease and cardiovascular events early after liver transplantation

Samarth S Patel1, Fei-Pi Lin2, Viviana A Rodriguez3

  • 1Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.

Insights

Cardiovascular complications are a leading cause of death after liver transplantation (LT). This study found no link between coronary artery disease (CAD) severity and these events, with diabetes being a key risk factor.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Cardiovascular complications significantly contribute to mortality following liver transplantation (LT).
  • Assessing coronary artery disease (CAD) non-invasively is challenging in cirrhotic patients.
  • Accurate CAD assessment is crucial for managing cardiovascular risk in LT candidates.

Purpose of the Study:

  • To evaluate cardiovascular events after LT.
  • To stratify outcomes based on the presence and severity of CAD.
  • To identify predictors of cardiovascular complications post-LT.

Main Methods:

  • Retrospective analysis of 283 LT patients who underwent pre-LT coronary angiography.
  • Coronary angiography performed for patients >50 years, with CAD history, abnormal stress tests, or risk factors.
  • Primary outcome: composite cardiovascular events within 4 weeks post-LT (MI, cardiac arrest, stroke, cardiac death, heart failure, arrhythmia).

Main Results:

  • Coronary artery disease (CAD) was present in 32.5% of patients; 11.3% had obstructive CAD.
  • Overall cardiovascular events occurred in 25.4% of patients, most commonly arrhythmia (20.8%).
  • No significant relationship was found between CAD presence/severity and composite cardiovascular events; diabetes was independently associated (OR 2.62).

Conclusions:

  • Cardiovascular disease is a major cause of early mortality after LT.
  • The severity of coronary artery disease does not appear to be related to early cardiovascular complications post-LT.
  • Diabetes mellitus is a significant predictor of cardiovascular events in the LT population.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
415
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
246
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
359
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
658
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
464